Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxoprexin vs Dacarbazine in Metastatic Melanoma
NCT00087776Phase 3Terminated
- Sponsor
- American Regent, Inc.
- Start
- Dec 2002
- Primary completion
- Oct 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel docosahexaenoic acid in melanoma, sponsored by American Regent, Inc.. Started Dec 2002; status: terminated.
02
Drugs
paclitaxel docosahexaenoic acid
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00087776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087776.